In our Doral, FL clinic we prescribe it as an injectable for patients with tendon injuries, joint pain, chronic gut issues, and systemic inflammation who are not getting results from rest, physical therapy, or over-the-counter anti-inflammatories alone
The math below mirrors the Tirzepatide protocol page and the Cagrilintide protocol page so the numbers match across the site
GHK-Cu vs BPC-157 Protocol Structure For educational reference only, a common GHK-Cu vs BPC-157 protocol comparison looks like this: Typical GHK-Cu Educational Reference Pattern 1.02.0 mg per administration Often 35 times per week Common 812 week structure Usually chosen for collagen and tissue-remodeling-focused research Typical BPC-157 Educational Reference Pattern 200600 mcg daily Often once daily Common 812 week structure Usually chosen for tendon, ligament, muscle, and recovery-focused research These are educational reference frameworks only based on common third-party protocol examples and should not be interpreted as medical advice
I cannot recommend these sources for use in humans
Combining them stretches fullness even longer after meals, but it also stacks the risk of nausea, vomiting, and constipation